Empagliflozin and Major Renal Outcomes in Heart Failure.

Autor: Packer M; Baylor University Medical Center, Dallas, TX milton.packer@baylorhealth.edu., Butler J; University of Mississippi School of Medicine, Jackson, MS., Zannad F; Université de Lorraine, Nancy, France., Pocock SJ; London School of Hygiene and Tropical Medicine, London, United Kingdom., Filippatos G; National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Ferreira JP; Université de Lorraine, Nancy, France., Brueckmann M; Boehringer Ingelheim, Ingelheim, Germany., Jamal W; Boehringer Ingelheim, Ingelheim, Germany., Zeller C; Boehringer Ingelheim Pharma, Biberach, Germany., Wanner C; University Hospital of Würzburg, Würzburg, Germany., Anker SD; Charité Universitätsmedizin, Berlin, Germany.
Jazyk: angličtina
Zdroj: The New England journal of medicine [N Engl J Med] 2021 Oct 14; Vol. 385 (16), pp. 1531-1533. Date of Electronic Publication: 2021 Aug 27.
DOI: 10.1056/NEJMc2112411
Databáze: MEDLINE